Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Mar;16(3):303-9.

Successful prevention of tunneled, central catheter infection by antibiotic lock therapy using cefotaxime

Mojgan Mortazavi  1 , Samira Alsaeidi, Roohollah Sobhani, Fereshte Salimi, Abdolamir Atapour, Nima Sharif, Mojtaba Akbari, Bahram Pakzad, Amir Hosein Davarpanah Jazi
Affiliations

Successful prevention of tunneled, central catheter infection by antibiotic lock therapy using cefotaxime

Mojgan Mortazavi et al. J Res Med Sci. 2011 Mar.

Abstract

Background: Chronic hemodialysis patients frequently require vascular access through central venous catheters (CVCs). The most significant complication of these catheters is infection. This risk can be lowered by the use of an antibiotic-Heparin lock. This study focuses on hemodialysis patients using Tunneled-cuffed catheters (TCC), to assess the rate of catheter-related infections (CRI) in catheter-restricted filling with Cefotaxime and Heparin in end stage renal disease patients.

Methods: A double-blind randomized study was conducted to compare 5000 U/ml Heparin plus10 mg/ml cefotaxime (CE/HS) as catheter-lock solutions, with Heparin (5000 U/ml) alone. A total of 30 patients with end-stage renal disease and different etiologies, were enrolled for chronic hemodialysis with permanent catheters from December 2009 to March 2010. These patients were randomly assigned to two groups of 15 members. Blood samples were collected for culture, sensitivity, and colony count, from the catheter lumen and the peripheral vein. CRI was considered as the end point.

Results: The rate of CRI was significantly lower in the cefotaxime group versus control group (p < 0.001). No exit site infection was occurred in both groups. Infection-free survival rates at 180 days were 100% for the CE/HS group, and 56% for the HS group.

Conclusions: Antibiotic lock therapy using cefotaxime reduces the risk of CRI in hemodialysis patients.

Keywords: Catheter; Cefotaxime; Hemodialysis; Heparin; Lock Solution Infection.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interests Authors have no conflict of interests.

Figures

Figure 1
Figure 1
Study profile
See this image and copyright information in PMC

References

    1. Bristol: UK Renal Registry; 2005. UK Renal Registry. New Adult Patients Starting Renal Replacement Therapy in the UK in 2004; pp. 12–26.
    1. Allon M, Radeva M, Bailey J, Beddhu S, Butterly D, Coyne DW, et al. The spectrum of infection-related morbid-ity in hospitalized haemodialysis patients. Nephrol Dial Transplant. 2005;20(6):1180–6. - PubMed
    1. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2004. U.S. Renal Data System, USRDS 2004 Annual Data Report: Atlas of End-Stage Renal Disease in the United States.
    1. Saxena AK, Panhotra BR. The impact of catheter-restricted filling with cefotaxime and heparin on the lifespan of temporary hemodialysis catheters: a case controlled study. J Nephrol. 2005;18(6):755–63. - PubMed
    1. Pastan S, Soucie JM, McClellan WM. Vascular access and increased risk of death among hemodialysis patients. Kidney Int. 2002;62(2):620–6. - PubMed

LinkOut - more resources